• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Emcure Pharmaceuticals Limited — Updates, 10-11-2025: Press Release

    10-11-2025 | 11:21 am

    Emcure Pharma secures exclusive distribution rights for Novo Nordisk's Poviztra® (semaglutide injection 2.4 mg) in India. This strategic partnership expands Emcure's weight-loss drug portfolio and market presence.

    No comments yet. Be the first to comment!

    All announcements from Emcure Pharmaceuticals Limited